Restriction lift date: 2027-12-31
Evaluation of the role of MxA in oesophageal cancer
Loading...
Files
Date
2024
Authors
Hayes, Robert Michael
Journal Title
Journal ISSN
Volume Title
Publisher
University College Cork
Published Version
Abstract
Oesophageal cancer is the seventh most common cancer worldwide and the sixth leading cause of cancer death. The incidence of oesophageal cancer is predicted to increase by 30% by the year 2040, however five-year survival remains at 20% in Ireland. There are two main subtypes, oesophageal squamous cell carcinoma and oesophageal adenocarcinoma. Both are aggressive cancers which frequently develop resistance to chemotherapeutics. Thus, novel therapeutic options are needed. Myxovirus resistance A (MxA) is an interferon inducible antiviral protein that is frequently upregulated in oesophageal cancer. It is currently unknown whether MxA plays a role in the development and progression of oesophageal cancer.
We investigated the relationship between MxA expression and the response to chemotherapeutics (5-fluorouracil and oxaliplatin) in oesophageal cancer cell lines. MxA was differentially expressed in five oesophageal cancer cell lines. KYSE450 and KYSE140 cells did not express MxA and were apoptosis incompetent. FLO-1, KYSE270 and OE21 cells expressed MxA and were apoptosis competent. MxA was artificially overexpressed in cell lines without endogenous expression. This increased the resistance of KYSE450 but not KYSE140 cells. Both cell lines remained apoptosis incompetent. MxA expression was depleted in FLO-1 cells using siRNA, and in OE21 cells using CRISPR knockout. Knockdown of MxA significantly increased drug sensitivity and caspase-3 activation in FLO-1 cells. OE21-MX1KO cells were also more drug-sensitive, but caspase-3 activation was reduced. Therefore, these data indicate MxA can influence drug sensitivity, but this is not always related to apoptosis.
We examined the impact of MxA on autophagy. Loss of MxA led to significant elevation of basal and drug-induced autophagy in all cell lines. Limited colocalisation was observed between MxA and the autophagosome marker LC3, suggesting MxA’s negative regulatory effect on autophagy is unlikely to involve direct interaction with autophagosomes. MxA was distributed in variably sized, discrete structures which were more numerous and peripherally located following treatment with a proteasome inhibitor or oxaliplatin. We also found that MxA is a significant component of the secretome of oesophageal cancer cells. This secretome included the mitochondrial protein TOM20. MxA knockout diminished the secretion of TOM20 from cells, in conjunction with the autophagy marker LC3. Therefore, we have established that MxA plays a role in the secretion of mitochondria and may act at the intersection between autophagic degradation and export of cellular material in oesophageal cancer cells.
We evaluated the effects of MxA knockout on gene expression by RNAseq analysis. 868 genes were differentially expressed, including interconnected networks of genes involved in cell motility, immune/inflammatory signalling, metabolism, and cell differentiation. 59 differentially expressed genes overlapped with genes affected by inhibition of HDAC6, a central mediator of cancer associated pathways. We examined a potential interaction between MxA and HDAC6. Immunofluorescence analysis of OE21 and FLO-1 cells identified colocalisation between MxA and HDAC6 in particulate structures resembling stress granules. Colocalisation was increased in response to treatment with a chemotherapeutic agent or proteasomal inhibitor. Co-immunoprecipitation analysis indicated a specific interaction between MxA and HDAC6. We then compared migration in OE21 and OE21-MX1KO cells. A wound-healing assay demonstrated that migration was significantly reduced in MxA KO cells.
Therefore, our data indicates a diverse role for MxA in oesophageal cancer biology. Depletion of MxA expression increased sensitivity to chemotherapeutics. MxA knockout resulted in differential expression of interconnected networks of genes which are associated with cancer progression. MxA negatively regulated autophagy and promoted secretion. A novel interaction between MxA and HDAC6 was identified, which may have significant consequences for the activity of both proteins. Importantly, as depletion of MxA can increase drug sensitivity and reduce migration, targeting this protein may be beneficial for the treatment of oesophageal cancer in future.
Description
Keywords
MxA , Oesophageal cancer , Apoptosis , Autophagy , Secretion , HDAC6 , Drug resistance
Citation
Hayes, R. M. 2024. Evaluation of the role of MxA in oesophageal cancer. PhD Thesis, University College Cork.